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Drugs and the Blood-Testis Barrier
by B. P. Setchell* and S. J. Main*
The functional and morphological evidence for the blood-testis barrier is discussed, together with
evidence for the various processes (simple diffusion and facilitated diffusion) by which various substances
enter the seminiferous tubule. Data are presented to show that methylmethane-sulfonate (MMS) and
dimethyinitrosamine (DMNA) both enter the seminiferous tubules rapidly, although from the published
rates of methylation of testicular DNA, by these two compounds, it might be expected that the entry of
DMNA would be slower than that of MMS. It appears, however, that DMNA in blood is graduaily
converted to some nonpermeant compound. The possibility, as yet unsubstantiated, is discussed that a
nontoxic permeant precursor may be converted into a nonpermeant toxic substance inside the tubules,
thereby effectively concentrating the toxic compound inside the tubules.
The germinal cells in the testis are separated from
the blood stream by the blood-testis barrier. Evi-
dence for this barrier can be found in experiments
done early in this century involving injections ofdyes
(1), but the significance of these and later observa-
tions was overlooked until it was noticed that the
exclusion of dye did not occur before puberty (2).
Physiological evidence for a barrier was forthcoming
when techniques were developed for collecting fluid
from the rete testis and the seminiferous tubules.
Rete testis fluid can be collected by chronic
catheterization in several species and acutely in
others (1, 3). Seminiferous tubular fluid can be col-
lected inrats and hamsters directly by micropuncture
(4-6) or its composition can be calculated indirectly
after efferent duct ligation (7). (The ionic composi-
tion of tubular fluid calculated by the indirect "dif-
ference" technique was found to be very similar to
that of tubular fluid collected directly by mic-
ropuncture.) Both rete testis and seminiferous tubule
fluids are appreciably different in composition from
blood plasma or testicular lymph (3, 4), and these
differences would not be maintained unless there
were some restriction on the entry ofsubstances into
the seminiferous tubules and rete testis.
By infusing radioactive markers intravenously
during the collection of rete testis fluid (1, 8) and
seminiferous tubular fluid (6, 7), it has been shown
directly that the exchange of substances between
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the fluid outside the tubules and the fluid inside can
vary over a wide range, from almost instantaneous
entry (e.g., tritiated water and ethanol) to almost
complete exclusion (e.g. albumin and inulin). The
rate ofentry does notdependjust on molecularsize,
although in general the larger molecules do enter
more slowly; substances with high lipid solubility
enter more rapidly than hydrophilic compounds.
The barrier has been located anatomically (9-11)
at the specialized junctions which develop at pub-
erty between pairs ofSertoli cells (12, 13). For some
species, the peritubular tissues, particularly the
myoid cells, also present some restriction to the
entry of large electron-opaque substances (9, 10).
Some substances (e.g., glucose) enter the tubules
by a process of facilitated diffusion (14) and for
these compounds there are specific carrier mech-
anisms operating in the tubular wall, probably in
the Sertoli cells. Steroids enter at widely different
rates; testosterone enters relatively quickly but the
closely related compound 5a-dihydrotestosterone
(DHT) enters much less quickly (15, 16), although it
is slightly more lipid-soluble. Only the free steroid
enters the tubules; steroids bound to protein (e.g.,
after injections of antiserum to an albumin conju-
gate ofthe steroid) do not enter the tubules (Fig. 1).
This would presumably apply to any drug which is
strongly bound to plasma proteins.
Studies with androstenedione are particularly in-
teresting. When radioactive androstenedione was
infused intravenously, appreciable amounts of
radioactivity appeared in the seminiferous tubule
and rete testis fluids. However, practically none of
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FIGURE 1. Concentrations oftestosterone (free + protein-bound)
in blood plasma from the aorta and testicular vein and in rete
testis fluid: (solid bars) normal rats; (shaded bars) rats in-
jected with a sheep antiserum to testosterone 3-car-
boxymethyloxime-3-bovine serum albumin (0.6 ml/rat as
three intraperitoneal injections over 21 hr; the blood samples
were taken 3 hr after the last injection.
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FIGURE 2. Transfer constants, K = -(lIt) ln [C, - (CRTFICA)] for
some barbiturates (closed symbols), and sulfonamides (open
symbols), and (0) salicylic acid from blood plasma into rete
testes fluid in rats, plotted against the partition coefficient
(PC) between chloroform and phosphate buffer (pH 7.4) and
molecular weight (MW), where t is time (min) after beginning
of infusion; Cp is concentration in blood plasma, and CRTF iS
concentration in rete testis fluid: (0) thiopental; (A) pen-
tobarbital; (O) barbital; (0) sulfanilamide; (A) sulfaguanidine;
(E) sulfamethoxypyridazine. Note that the high transfer con-
stants are associated with a high chloroform partition coeffi-
cient. There is no relation with molecular weights; ifanything
there is a suggestion that the larger molecules penetrate
slightly more quickly. Data from Okamura et al. (17).
this radioactivity was present as the infused com-
pound, most being associated with testosterone (15,
16). It is likely that this was formed in the interstitial
tissue and entered the tubules as testosterone, be-
cause a large fraction ofthe radioactivity in testicu-
lar venous blood was also present as testosterone
(16). These experiments emphasize the need to
identify the radioactivity present in the testicular
fluids, and, particularly with compounds which may
be metabolized by the interstitial tissue, to examine
the pattern of radioactivity in testicular venous as
well as arterial blood.
Comparatively few studies have been made on
the entry of foreign substances into the seminifer-
ous tubules and rete testis. By using a range ofbar-
biturates, sulfonamides, and salicylic acid, it was
shown that entry rate depended on lipid solubility,
and could vary widely (17) (Fig. 2). A number of
esters of dimethanesulfonic acid have also been
studied; all entered rete testis fluid at appreciable
rates (Fig. 3) but had reached only about 20%o of
blood levels after 2 hr (18). The antifertility com-
pound, a-chlorhydrin, enters rete testis fluid almost
as quickly as tritiated water (19). The entry of two
mutagens, methylmethanesulfonate (MMS) and di-
methylnitrosamine (DMNA) into rete testis fluid
and seminiferous tubular fluid has also been exam-
ined. As the methylation of DNA in the testis was
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FIGURE 3. Ratios of radioactivity in rete testis fluid to that in
blood of rats following intraperitoneal injection of various
esters of dimethanesulfonic acid as suspensions in 30%o di-
methyl sulfoxide-arachis oil (2 ml/kg body weight): (0)
methylene dimethanesulfonate (15 mg/kg); (0) ethane-1,2-
dimethanesulfonate (2, 50 or 75 mg/kg); (E) propane-1,3-
dimethanesulfonate (50 mg/kg); (K) butane-1,4-dimethane-
sulfonate (Busulphan or Myleran, 4 or 10 mg/kg); (A) no-
nane-1,9-dimethanesulfonate (9 or 200 mg/kg). The doses
used had been previously shown to have antifertility effects.
Data from Waites et al. (18).
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z lmuch less with DMNA than with MMS (20) it was
anticipated that the entry of DMNA would be
slower than that ofMMS. In fact, total radioactivity
had reached equilibrium between rete testis fluid
and seminiferous tubular fluid and blood plasma
within 1 hr after the injection of either substance
(Figs. 4 and 5). It was not possible to identify the
nature of the radioactivity present in the various
fluids, but it is interesting that the testicular
fluids:plasma ratios decreased with time after injec-
tion of DMNA. This was presumably due to the
appearance of nonpermeant metabolites in the
plasma, derived from extratesticular sources.
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FIGURE 4. Ratios of total radioactivity in (-) rete testis fluid or
(0) seminiferous tubule fluid, calculated as described (7) for
"additional tubular fluid," to that in blood plasma at various
times after intravenous injection of [14C] methyl
methanesulfonate (Radiochemical Centre, Amersham and
Aldrich Chemical Co., 7 uCi, 100 mg/kg body weight).
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FIGURE 5. Ratios of total radioactivity in (O) rete testis fluid or
(0) seminiferous tubule fluid (see Fig. 4) to that in blood
plasma at various times after intraperitoneal injection of
N,N-di[14C] methylnitrosamine (Radiochemical Centre,
Amersham and Aldrich Chemical Co., 5 IACi, 30 mg/kg body
weight). This dose has no obvious toxic effects on the testes
ofwell-fed rats (21).
Another most important theoretical possibility,
which has not yet been actually observed, is that a
permeant substance could be transformed inside the
seminiferous tubules into a nonpermeant, toxic
metabolite. Because the latter could not escape
from the tubules, it would tend to accumulate there
in concentrations much higher than if the toxic
metabolite itself were given to the animal. Impor-
tant mutagenic effects may thereby result at com-
paratively low doses of the precursor.
Clearly, the blood testis barrier is a very impor-
tant factor to consider in any studies on drugs which
may affect the germinal epithelium of the testis.
Lipid-soluble compounds would probably penetrate
readily into the tubules but large hydrophilic
molecules and substances which bind to plasma
proteins usually penetrate only slowly. The barrier
could exclude potentially harmful substances from
the tubules, but equally it would lead to an ac-
cumulation of toxic compounds there.
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